Symptoms of low blood sugar can include dizziness, lightheadedness, sweating, hunger, confusion, or shakiness
Sitagliptin, anagliptin, gemigliptin, and teneligliptin form class 3 of the DPP-4 inhibitors (see Figure 2) ( Figure 2 The clinically most relevant and important action of DPP-4 inhibitors is the endogenous elevation of the incretin hormone concentration of GLP-1 that consecutively leads to a glucose-dependent stimulation of insulin secretion and an inhibition of glucagon secretion ( This article gives an overview on the characteristics of the various DPP-4 inhibitors in clinical use and highlights the positioning of the drug class in the guidelines for the treatment of type 2 diabetes
10 questions Takes about 2 minutes Not All GLP-1 Coverage Works the Same Coverage depends not just on the drug, but on why it is prescribed
Adequate intake protects against cancer, cardiovascular, neurodegenerative, and inflammatory diseases, while deficiency worsens outcomes
Filed Under: clinical trials, Drug Discovery, Endocrinology, Gastroenterology, Uncategorized
The medication works mainly by mimicking a natural hormone called GLP-1 (glucagon-like peptide-1)
